AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11682660
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg daily for 4 weeks
Trial: 8206188
Drug: Implantable programmable
RxNorm normalized name: PUMP,LUTREPULSE PROGRAMMABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable programmable insulin pumps (IMP)
Trial: 31141505
Drug: Cinacalcet treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinacalcet treatment
Trial: 28833652
Drug: 5% topical
RxNorm normalized name: BP 5% Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% topical vitamin C applied twice daily
Trial: 27133311
Drug: Triple antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple antiplatelet therapy (TAPT) - aspirin plus clopidogrel plus cilostazol; cilostazol loading dose of 100 mg bid for 1 week
Trial: 27133311
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (DAPT) - aspirin plus clopidogrel; no cilostazol
Trial: 24469880
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg ASA
Trial: 23212718
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg clopidogrel
Trial: 7049709
Drug: supidimide 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: supidimide 2 x 200 mg per day
Trial: 6360575
Drug: Verapamil 160
RxNorm normalized name: verapamil 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 160 mg bd
Trial: 6360575
Drug: Verapamil 80
RxNorm normalized name: verapamil 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 80 mg qd
Trial: 20350429
Drug: Endotracheal lavage
RxNorm normalized name: lovage oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endotracheal lavage (2-3 times daily)
Trial: 30844848
Drug: Allergen immunotherapy
RxNorm normalized name: Allergen immunotherapy extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allergen immunotherapy
Trial: 10417667
Drug: Control vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control vaccine (inactivated polio vaccine)
Trial: 29192549
Drug: AMP XR-OS
RxNorm normalized name: Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMP XR-OS (15 mL)
Trial: 29192549
Drug: Adderall XR
RxNorm normalized name: Adderall XR
DrugBank: Dextroamphetamine (DB01576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adderall XR (30 mg capsule)
Trial: 30156314
Drug: Fosravuconazole L-lysine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosravuconazole L-lysine ethanolate (100 mg RVCZ, n = 101)
Trial: 27374360
Drug: Leukocyte-platelet rich
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leukocyte-platelet rich fibrin (L-PRF) with allogenous bone graft
Trial: 12575567
Drug: Tongmai Yizhi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tongmai Yizhi capsule (TMYZC)
Trial: 2452123
Drug: 0.10 mg
RxNorm normalized name: povidone-iodine 0.10 mg in 1 mL TOPICAL SOLUTION [Povidone Iodine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.10 mg of rIFN‐gamma administered daily for 28 days
Trial: 2452123
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (0.25 mg and 0.10 mg of rIFN‐gamma)
Trial: 29775141
Drug: Daily activities
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily activities (Control)
Trial: 30736102
Drug: Tailored exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored exercise protocol during hospitalization, 15 to 30 minutes daily, supervised by an exercise specialist.
Trial: 26467316
Drug: Routine clinical
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine clinical treatment
Trial: 2946608
Drug: Danazol therapy
RxNorm normalized name: Danazol
DrugBank: Danazol (DB01406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Danazol therapy
Trial: 25199824
Drug: Medication (MED)
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (MED)
Trial: 27568513
Drug: Heroin-assisted treatment
RxNorm normalized name: heroin
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heroin-assisted treatment (HAT)
Trial: 18281662
Drug: Gemcitabine (GEM)
DrugBank: Gemcitabine (DB00441)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Gemcitabine (GEM) 1,000 mg/m(2) on days 1, 8, and 15 every 28 days
Trial: 18281662
Drug: Pegylated liposomal
RxNorm normalized name: doxorubicin HCl pegylated liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated liposomal doxorubicin (PLD) 40 mg/m(2) every 28 days
Trial: 8686718
Drug: Intravenous antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous antibiotic treatment (oxacillin or vancomycin plus gentamicin)
Trial: 31653175
Drug: Medication effect
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication effect score
Trial: 29447787
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus P2Y12 inhibitor (DAPT)
Trial: 17173219
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with metronidazole and azithromycin
Trial: 11397720
Drug: Inogatran (low‐molecular‐mass
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inogatran (low‐molecular‐mass direct thrombin inhibitor)
Trial: 2967187
Drug: Bisoprolol 10-20
RxNorm normalized name: bisoprolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol 10-20 mg o.d.
Trial: 2967187
Drug: Nifedipine SR
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine SR 20-40 mg b.i.d.
Trial: 12003381
Drug: Cyanoacrylate glue
RxNorm normalized name: ethyl cyanoacrylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyanoacrylate glue injection
Trial: 20686410
Drug: Mupirocin ointment
RxNorm normalized name: Mupirocin Ointment
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin ointment (5-day course given monthly for 8 months)
Trial: 15988425
Drug: Ketamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine infusion (0.2 mg/kg bolus followed by 0.5 mg/kg/hour for 2 hours)
Trial: 15988425
Drug: Placebo (normal-saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal-saline infusion)
Trial: 10389787
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia followed by IV patient-controlled analgesia with morphine
Trial: 1653578
Drug: Simvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (20 mg die) for 6 months
Trial: 367979
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid 500 mg per day for 12 months
Trial: 367979
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid 500 mg per day for 6 months
Trial: 28947723
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg rivaroxaban
Trial: 8489836
Drug: Iodixanol 270
RxNorm normalized name: IODIXANOL 270mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodixanol 270 mg I/ml
Trial: 7946687
Drug: Iodixanol 320
RxNorm normalized name: IODIXANOL 320mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodixanol 320 mg I/ml
Trial: 29954183
Drug: Rifampin 15
RxNorm normalized name: rifampin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin 15 mg/kg/d
Trial: 29954183
Drug: All rifampin
RxNorm normalized name: Rifampin
DrugBank: Rifampin (DB01045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All rifampin doses
Trial: 27052839
Drug: Uninflated balloon
RxNorm normalized name: CATHETER,BALLOON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uninflated balloon treatment (control group)
Trial: 25179086
Drug: Melatonin supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin supplementation (5 mg daily for 90 days)
Trial: 24743802
Drug: D-cycloserine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-cycloserine (50 mg)
Trial: 17578790
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of efavirenz therapy
Trial: 15626320
Drug: 1.5 mg/mL
RxNorm normalized name: thymol 1.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/mL rhBMP-2
Trial: 11409559
Drug: 15 ml
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 ml of isotonic saline solution (control group)
Trial: 16856319
Drug: Pea fiber
RxNorm normalized name: Pea fiber
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pea fiber diet (33 g pea fiber product/10 MJ)
Trial: 16856319
Drug: Pea fiber
RxNorm normalized name: Pea fiber
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pea fiber added to breakfast (12 g/10 MJ) and lunch (15 g/10 MJ)
Trial: 26089183
Drug: Encenicline 0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Encenicline 0.9 mg
Trial: 26089183
Drug: Encenicline 0.27
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Encenicline 0.27 mg
Trial: 24008606
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg Pycnogenol
Trial: 21794974
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with a history of intravesical therapy
Trial: 17239987
Drug: 1320-nm Nd:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1320-nm Nd:YAG laser therapy
Trial: 23270285
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline solution (SS)
Trial: 12393770
Drug: Lactated Ringers
RxNorm normalized name: lactated ringers
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringers solution (RL)
Trial: 7925517
Drug: pimobendan (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pimobendan (average 10.3 mg.day‐1, n = 119)
Trial: 7925517
Drug: enalapril (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: enalapril (average 10.7 mg.day‐1, n = 123)
Trial: 2531972
Drug: Topically applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topically applied local anaesthetic cream (EMLA)
Trial: 28192673
Drug: Melatonin 100
RxNorm normalized name: melatonin 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 100 mg·day‐1
Trial: 26317257
Drug: Any antiplatelet/anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any antiplatelet/anticoagulant therapy
Trial: 26317257
Drug: ACE inhibitors/angiotensin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitors/angiotensin II antagonist therapy
Trial: 26317257
Drug: Any method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any method to stop smoking, lipid lowering agents, antiplatelet and/or anticoagulation therapy, and any kind of exercise program
Trial: 24340989
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of 0.4 mg/kg/hr rocuronium bromide (esmeron) in group 1 (n = 14)
Trial: 24340989
Drug: Bolus administration
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus administration of 0.15 mg/kg/hr esmeron in group 2 (n = 11)
Trial: 26065566
Drug: Continuous positive
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous positive airway pressure treatment
Trial: 31686255
Drug: High-power therapeutic
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-power therapeutic ultrasound with neutral gel
Trial: 12184352
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment for back pain
Trial: 25081728
Drug: Hepatectomy combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatectomy combined with 'Jianpi Huayu Therapy' (treatment group)
Trial: 11566656
Drug: Dairy product
RxNorm normalized name: Food - Dairy Products, Whey, Cow's Milk
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dairy product consumption >2.5 servings daily
Trial: 11566656
Drug: Skim milk
RxNorm normalized name: skim milk
DrugBank: Skim milk (DB15546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skim milk consumption >600 mg Ca/d
Trial: 31115192
Drug: Routine supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine supportive care plus CIM intervention (nurse-led supportive care intervention using Complementary and Integrative Medicine)
Trial: 15786902
Drug: Oral insertion
RxNorm normalized name: Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral insertion
Trial: 29987109
Drug: Sitagliptin 100
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 100 mg/d
Trial: 23890686
Drug: Ecologically‐Based Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ecologically‐Based Treatment (n=30)
Trial: 19747427
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A (240 mg in four doses)
Trial: 15061347
Drug: Manual-assisted cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual-assisted cognitive behavior therapy (MACT)
Trial: 7495235
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus vitamin E [0.4 g (400 IU)/d; n = 52]
Trial: 7495235
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (325 mg; n = 48)
Trial: 7495235
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus vitamin E
Trial: 27312203
Drug: DMARD combinations
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMARD combinations or biologic agents
Trial: 27312203
Drug: Methotrexate monotherapy
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate monotherapy or steroid and DMARD combinations
Trial: 21501494
Drug: L-lysine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-lysine (6 g/day)
Trial: 16131600
Drug: GH therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH therapy (1.2 IU/day for men and 1.8 IU/day for women)
Trial: 28877893
Drug: Bifidobacteria-supplemented formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bifidobacteria-supplemented formula (107 CFU/g of Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum, B. longum subspecies infantis)
Trial: 14597641
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg aliskiren
Trial: 388083
Drug: Adriamycin chemotherapy
RxNorm normalized name: Adriamycin
DrugBank: Doxorubicin (DB00997)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adriamycin chemotherapy
Trial: 30407039
Drug: Motivational Interviewing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivational Interviewing integrated with Cognitive-Behavioral Therapy (MI-CBT)
Trial: 16159704
Drug: Intravenous midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous midazolam (group 1)
Trial: 8874907
Drug: 80 micrograms.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 micrograms. kg‐1 morphine
Trial: 28851314
Drug: Arm A
RxNorm normalized name: Warm antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm A (4 weeks of oral S-1 and a 2-week rest over 12 months)
Trial: 23229932
Drug: High-efficiency OL-HDF
RxNorm normalized name: limonen-10-ol, (+)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-efficiency OL-HDF (subgroup with median substitution volume >17.4 L per session)
Trial: 18586462
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of Zn supplementation (as Zn sulfate)
Trial: 8166893
Drug: morphine/bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: morphine/bupivacaine
Trial: 24656609
Drug: Washout and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Washout and re-initiation group (300 mg daclizumab HYP)
Trial: 24656609
Drug: Continuous treatment
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous treatment group
Trial: 24656609
Drug: Treatment initiation
RxNorm normalized name: Otezla 10mg-20mg 28-Day Treatment Initiation Pack Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment initiation group
Trial: 21525406
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy (IC) with cisplatin 75 mg/m(2), epirubicin 75 mg/m(2) and paclitaxel (Taxol) 175 mg/m(2) (CEP) followed by concomitant radiotherapy (RT) and weekly cisplatin 40 mg/m(2)
Trial: 8791030
Drug: 311C90 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 311C90 20 mg
Trial: 25096769
Drug: Esmolol infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol infusion (0.5 mg/kg/min)
Trial: 22101221
Drug: Carboplatin administered
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin administered by convection-enhanced delivery (CED)
Trial: 9809131
Drug: Low-dose LAAM
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose LAAM (165 mg/week)
Trial: 7915916
Drug: IL‐1 alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL‐1 alpha treatment
Trial: 23085134
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg orally)
Trial: 1233219
Drug: Metoprolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (40 mg orally)
Trial: 29428459
Drug: Ritonavir‐boosted protease
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir‐boosted protease inhibitor (PI) monotherapy
Trial: 26698263
Drug: Atorvastatin combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin combined with trimetazidine
Trial: 21876312
Drug: Levamisole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (100 mg orally for 12 days)
Trial: 18180678
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Control group, n=23)
Trial: 10921543
Drug: Postpyloric paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postpyloric paracetamol administration
Trial: 10921543
Drug: Gastric paracetamol
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastric paracetamol administration
Trial: 10921543
Drug: Paracetamol pharmacokinetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol pharmacokinetic study
Trial: 10921543
Drug: Opiate dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opiate dose
Trial: 8726596
Drug: Methylprednisolone, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone, administered early
Trial: 8726596
Drug: New pharmacologic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New pharmacologic agents (not specified)
Trial: 1571340
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (cyclosporine, azathioprine, and prednisolone)
Trial: 30277639
Drug: ABVE-PC chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABVE-PC chemotherapy
Trial: 22151619
Drug: Topical morphine
RxNorm normalized name: morphine Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical morphine gel
Trial: 23093481
Drug: Imdur® Long-Acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imdur® Long-Acting tablet 60 mg
Trial: 7970009
Drug: Tizanidine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tizanidine (2 mg to a maximum of 36 mg/d; weeks 2 to 4)
Trial: 3620284
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of triprolidine 2.5 mg and dipipanone 8 mg
Trial: 26992271
Drug: Standard pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pain control with acetaminophen and opioids (SPC)
Trial: 26992271
Drug: Standard pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pain control plus gabapentin (SPC+G)
Trial: 23903371
Drug: AMG 416
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 416 (velcalcetide) 10 mg or more
Trial: 22171015
Drug: Adjuvanted A/H1N1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvanted A/H1N1 influenza vaccine